Recent Publications

Records 24 / 2080

The practitioner's dilemma: can we use a patient's race to predict genetics, ancestry, and the expected outcomes of treatment?

December 2005

Recent research has identified genetic traits that can be used in a laboratory setting to distinguish among global population groups.

Frequency of HIV Screening in the Veterans Health Administrations: Implications for Early Diagnosis of HIV Infection

December 2008

We evaluated the frequency of HIV testing across the Department of Veterans Affairs (VA), the largest provider of HIV care in the United States.

Evaluating Human Papillomavirus Vaccination Programs

November 2004

Human papillomavirus (HPV) has been implicated as the primary etiologic agent of cervical cancer. Potential vaccines against high-risk HPV types are in clinical trials.

Computer Program for Statistically-Based Decision Analysis, A

December 1990

Multivariate Analysis of Mortality and Hospital Admission Rates of High-Flux Dialysis, A

December 1992

Alglucerase for Gaucher's Disease: Dose, Costs, and Benefits

December 1994

Antibiotic Exposure and Resistance in Mixed Bacterial Populations

December 1987

Benefits vs Profits: Has the Orphan Drug Act Gone Too Far?

December 1994

Can Technology Assessment Control Health Spending?

December 1994

Because medical technology is the most important controllable component of health spending growth, the success of strategies for limiting spending growth depends upon their impact on technology...

Case Mix, Costs, and Outcomes: Differences between Faculty and Community Services in a University Hospital

December 1984

Cholesterol Screening Guidelines: Consensus, Evidence, and Common Sense

December 1997

Cholesterol Screening in Asymptomatic Adults, Revisited

December 1996

Cholesterol Screening Should Be Targeted

December 1997

Cost-Containment and Financing the Long-Term Care of the Elderly

December 1988

Cost-Effectiveness Analysis as a Measure of Value

December 1996

Cost-Effectiveness of Three Methods to Enhance the Sensitivity of Papanicolaou Testing

December 1999

Also a 1998 research report: Medical Advisory Panel, TEC Program, Blue Cross Blue Shield Association

Cost-Effectiveness of Screening for Carotid Stenosis in Asymptomatic Individuals

December 1997

Costs and Benefits of Prenatal Screening for Cystic Fibrosis

December 1991

Costs and Health Consequences of Cholesterol Screening for Asymptomatic Older Americans

December 1991

Creating the Costliest Orphan: The Orphan Drug Act in the Development of Ceredase

December 1992


Owens1 Douglas K. Owens Senior Fellow Professor, Medicine (CHP/PCOR)
Steve Luby Headshot Stephen P. Luby Senior Fellow Professor, Medicine (CHP/PCOR)
rsd15 081 0253a Paul H. Wise Senior Fellow Senior Fellow , Professor, Pediatrics (CHP/PCOR)
michelle mello Michelle Mello Professor, Medicine (CHP/PCOR), Professor, Law
rsd15 055 0123a Grant Miller Senior Fellow Professor, Medicine (CHP/PCOR)
Joshua Salomon of Stanford Health Policy Joshua Salomon Senior Fellow Professor, Medicine CHP/PCOR
rsd15 081 0344a Jay Bhattacharya Senior Fellow by Courtesy Professor, Medicine (CHP/PCOR)
1 RSD13 085 0052a 001 David Relman Senior Fellow Professor, Medicine, Professor, Microbiology and Immunology
default people 100x120 Daniel P. Kessler Professor, Law, Professor, Political Economy
default people 100x120 Marcus W. Feldman Professor, Biology
Yock bio Paul Yock Professor, Medicine, Professor, Bioengineering
22940078479 cc5040fcbc o Eric Sun Assistant Professor, Anesthesiology